content

Recipharm acquires GenIbet to bolster Biologics offering

Global contract development and manufacturing organisation (CDMO), Recipharm, has today announced the acquisition of GenIbet, a Portuguese CDMO, specialising in the manufacture of biological...

Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis

Samsung Biologics announced that it has reached an agreement with Biogen for the buyout of Biogenโ€™s stake in the Samsung Bioepis joint venture for...

Scitara joins BioPhorum global collaboration to drive scientific advancements in biopharmaceutical sector

Scitara, proven innovator in laboratory digital transformation, announces it has become a member of BioPhorum, a global community that enables collaboration throughout the biopharmaceutical...

Nasal Covid-19 Vaccine From Bharat Biotech, A Possibility

Bharat Biotech has been granted permission by Indiaโ€™s drug controller to execute standalone phase 3 clinical trials on the intranasal vaccine for COVID-19. Besides...

Cryoport and Cell Matters Enter into Strategic Partnership

Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced that it has entered into a strategic partnership...

Recipharm secures vaccine manufacturing deal

Global contract development and manufacturing organization (CDMO), Recipharm, has inked a deal with a top 10 big pharma company to support vaccine manufacturing from...

Pandemic Far From Over As New Variants Keep Us On The Edge

KEY POINTS According to the WHO's top official, present conditions are suitable for COVID-19 to mutate more variants, and it is a high presumption...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read